Article
Biochemistry & Molecular Biology
Christiane Majer, Holger Lingel, Aditya Arra, Hans-Gert Heuft, Dirk Bretschneider, Silke Balk, Katrin Vogel, Monika C. Brunner-Weinzierl
Summary: Newborn CD4 T-cells show activation-induced events and produce Th1 cytokines in response to Staphylococcus aureus, indicating their ability to mount immediate and controlled antibacterial responses. The proliferation of neonatal T-helper cells is influenced by sex, IL-2 receptor expression, and the PD-1/PD-L1 axis. In addition, the regulation of multifunctional T-helper cells is exclusively mediated by the PD-1/PD-L1 axis in neonatal CD4 T-cells.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Review
Biochemistry & Molecular Biology
David Escors, Ana Bocanegra, Luisa Chocarro, Ester Blanco, Sergio Pineiro-Hermida, Maider Garnica, Leticia Fernandez-Rubio, Ruth Vera, Hugo Arasanz, Grazyna Kochan
Summary: PD-L1/PD-1 blockade immunotherapy has revolutionized cancer treatment, but its mechanisms and effectiveness are still not fully understood. This article reviews the evidence supporting the role of CD4 T cells in anti-tumor immunity and their potential as predictors of response to PD-L1/PD-1 blockade immunotherapy.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Oncology
Jiang Liu, Degan Liu, Guangyin Hu, Jingjing Wang, Dadong Chen, Chuanjun Song, Yin Cai, Chentong Zhai, Wenjing Xu
Summary: This study investigated the predictive values of circulating CD8(+) T cells and CD8(+)T/CD4(+)T cell ratio in advanced gastric cancer patients receiving immunotherapy. The results showed that patients with higher percentages of CD8(+) T and CD8(+) Tm expressing PD-1, as well as a higher PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio, had better survival outcomes. These findings provide preliminary evidence for screening the population that would benefit from immunotherapy.
CANCER CELL INTERNATIONAL
(2023)
Article
Oncology
Carlos Martinez-Gomez, Marie Michelas, Clara-Maria Scarlata, Anna Salvioni, Carlos Gomez-Roca, Victor Sarradin, Francoise Lauzeral-Vizcaino, Virginie Feliu, Agnes Dupret-Bories, Gwenael Ferron, Jerome Sarini, Christel Devaud, Jean-Pierre Delord, Camille-Charlotte Balanca, Alejandra Martinez, Maha Ayyoub
Summary: This study identified a population of CD4 T cells expressing inhibitory receptors targeted by immunotherapy in the blood of cancer patients. It showed that high proportions of these cells prior to therapy were associated with a response to immunotherapy. The study also found that exhausted CD4 T cells, which contained low proportions of effector cytokine-producing cells, may play a role in clinical responsiveness to immunotherapy.
Article
Immunology
Yanxiong Shao, Jiayao Fu, Tianle Zhan, Junhao Yin, Jiabao Xu, Yifan Lu, Qi Luo, Chuangqi Yu
Summary: This study found that fangchinoline inhibits the proliferation and infiltration of CD4+ T cells in the salivary gland tissues of NOD/ShiLtj mice with SS by upregulating miR-506-3p to inhibit NFATc1 expression. The results suggest that NFATc1 might be a potential therapeutic target for SS.
INFLAMMOPHARMACOLOGY
(2023)
Article
Oncology
Kevin Kos, Camilla Salvagno, Max D. Wellenstein, Muhammad A. Aslam, Denize A. Meijer, Cheei-Sing Hau, Kim Vrijland, Daphne Kaldenbach, Elisabeth A. M. Raeven, Martina Schmittnaegel, Carola H. Ries, Karin E. de Visser
Summary: This study reveals that tumor-associated macrophages (TAMs) contribute to the accumulation of regulatory T cells (T-regs) in breast tumors by promoting the conversion of CD4(+) T cells into T-regs. It is found that TAMs directly promote the conversion of CD4(+) T cells into T-regs through TGF-beta, and indirectly enhance the accumulation of T-regs by enhancing PD-1 expression on CD4(+) T cells.
Editorial Material
Immunology
David G. Brooks, Pamela S. Ohashi
Summary: This article reveals how dendritic cells create a niche for the preservation of Tpex cells.
Article
Oncology
Minglu Xiao, Luoyingzi Xie, Guoshuai Cao, Shun Lei, Pengcheng Wang, Zhengping Wei, Yuan Luo, Jingyi Fang, Xingxing Yang, Qizhao Huang, Lifan Xu, Junyi Guo, Shuqiong Wen, Zhiming Wang, Qing Wu, Jianfang Tang, Lisha Wang, Xiangyu Chen, Cheng Chen, Yanyan Zhang, Wei Yao, Jianqiang Ye, Ran He, Jun Huang, Lilin Ye
Summary: The study demonstrates that heterologous prime-boost vaccination can effectively inhibit tumor growth and enhance the expansion, effector function, and clonal breadth of tumor-specific CD8(+) T cells. Additionally, this vaccination strategy also enhances the antitumor effects of PD-1/PD-L1 immunotherapy, while preventing the re-exhaustion of tumor-specific CD8(+) T cells.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2022)
Article
Multidisciplinary Sciences
Fabienne Mazerolles, Frederic Rieux-Laucat
Summary: The expression of co-signalling receptors on T cells plays a crucial role in regulating T cell responses, and an imbalance between activating and inhibitory signals may lead to autoimmunity. Research showed that activated TEFFs and TREGs express different co-signalling receptors, and the expression of PD-L1 on activated TEFFs is correlated with their proliferation.
Article
Immunology
Aditya Arra, Holger Lingel, Mandy Pierau, Monika C. C. Brunner-Weinzierl
Summary: PD-1 plays a crucial role in suppressing the differentiation and function of Tc17 cells, and blockade of PD-1 can effectively enhance tumor immune response. PD-1 signaling inhibits the expression of IL-17 and related transcription factors in Tc17 cells, and also suppresses the expression of IL-21 and IL-23 receptors specific to Tc17 cells. Inhibition of PD-1 leads to the conversion of Tc17 cells into Tc1 cells, which possess tumor control characteristics.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Immunology
Weiping Li, Ziran Bai, Jiaqing Liu, Yawei Tang, Chunlai Yin, Minli Jin, Lijun Mu, Xia Li
Summary: Aberrant-activated CD4+T cells, regulated by PD-1-mediated signals, are important in the pathogenesis of ITP. The frequency and phenotype of CD4+PD-1+T cells were evaluated, revealing their potential role as B-cell helpers and their higher levels of mitochondrial ROS. Inhibition of mtROS could regulate their function and reduce inflammatory cytokine secretion.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Oncology
Boris Duchemann, Marie Naigeon, Edouard Auclin, Roberto Ferrara, Lydie Cassard, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Aude Desnoyer, Francois-Xavier Danlos, Laura Mezquita, Caroline Caramella, Aurelien Marabelle, Benjamin Besse, Nathalie Chaput
Summary: The balance between circulating CD8(+)PD-1(+) and CD4(+)PD-1(+) is associated with the effectiveness of immune checkpoint blockade therapy in non-small cell lung cancer patients. PERLS in the blood sample can be a new indicator for evaluating treatment outcomes.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2022)
Article
Virology
Mohammad Haque, Fengyang Lei, Xiaofang Xiong, Yijie Ren, Hao-Yun Peng, Liqing Wang, Anil Kumar, Jugal Kishore Das, Jianxun Song
Summary: Antigen-specific CD8+ cytotoxic T lymphocytes derived from induced pluripotent stem cells (iPSCs) can efficiently suppress HIV replication and protect CD4+ T cells. Adoptive transfer of iPSC-CTLs significantly inhibited HIV replication in mice and promoted the generation of persistent anti-HIV memory T cells.
Article
Immunology
Panpan Zhang, Mu Wang, Yu Chen, Jieqiong Li, Zheng Liu, Hui Lu, Yunyun Fei, Ruie Feng, Yan Zhao, Xiaofeng Zeng, Wen Zhang
Summary: In IgG4-related disease, the percentages of peripheral T helper (Tph) like cells are significantly increased, with higher expression levels of CD38, CD25, and TIGIT, and lower levels of CCR7 and CD127. Patients with affected internal organs have higher levels of circulating Tph like cells. Furthermore, Tph like cells correlate with serum levels of IgG and IgG4, as well as peripheral plasmablast levels, suggesting their potential as promising biomarkers for disease activity monitoring.
CLINICAL IMMUNOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Anneline C. Hinrichs, Aike A. Kruize, Floris P. J. G. Lafeber, Helen L. Leavis, Joel A. G. van Roon
Summary: Primary Sjogren's syndrome (pSS) is characterized by B cell hyperactivity. This study found limited overlap between CXCR5- Tph cells and CCR9+ Tfh-like cells in pSS patients and healthy controls. The highest expression of PD-1/ICOS was found in CXCR5/CCR9 co-expressing T cells, which are enriched in pSS patients and may contribute to ongoing immune responses.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)